TrialLeukemia research2014

Four different regimens of farnesyltransferase inhibitor tipifarnib in older, untreated acute myeloid leukemia patients: North American Intergroup Phase II study SWOG S0432.

Harry P Erba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.